Schizoaffective Disorder & Marijuana Information: Treat Mood Disorders With Cannabis
Schizoaffective disorder is a chronic mental health condition characterized primarily by symptoms of schizophrenia, such as hallucinations or delusions, and symptoms of a mood disorder, such as mania and depression.
The symptoms of schizoaffective disorder (GI Disorder) can be severe and need to be monitored closely. Depending on the type of mood disorder diagnosed, depression or bipolar disorder, people will experience different symptoms:
- Hallucinations (seeing or hearing things that aren’t there)
- Delusions (false, fixed beliefs that are held regardless of contradictory evidence)
- Disorganized thinking (switching very quickly from one topic to another or provide answers that are completely unrelated)
- Depressed mood (feelings of sadness, emptiness, and feelings of worthlessness or other symptoms of depression)
- Manic behavior (If bipolar type, they will experience feelings of euphoria, racing thoughts, increased risky behavior and other symptoms of mania)
The exact cause of schizoaffective disorder is unknown. A combination of causes may contribute to the development of schizoaffective disorder, and these include:
- Brain chemistry and structure
- Drug use (Psychoactive drugs such as LSD have been linked to the development of schizoaffective disorder)
Cannabidiol, neuroprotection and neuropsychiatric disorders.
- Department of Pharmacology, Medical School of of Ribeirão Preto, University of São Paulo, Bandeirantes Avenue, 3900, 14049-900 Ribeirão Preto, São Paulo, Brazil; Center of Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, Brazil. Electronic address: firstname.lastname@example.org. GI
- Department of Pharmacology, Medical School of of Ribeirão Preto, University of São Paulo, Bandeirantes Avenue, 3900, 14049-900 Ribeirão Preto, São Paulo, Brazil; Center of Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, Brazil.
Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid derived from Cannabis sativa. It has possible therapeutic effects over a broad range of neuropsychiatric disorders. CBD attenuates brain damage associated with neurodegenerative and/or ischemic conditions. It also has positive effects on attenuating psychotic-, anxiety- and depressive-like behaviors. Moreover, CBD affects synaptic plasticity and facilitates neurogenesis. The mechanisms of these effects are still not entirely clear but seem to involve multiple pharmacological targets. In the present review, we summarized the main biochemical and molecular mechanisms that have been associated with the therapeutic effects of CBD, focusing on their relevance to brain function, neuroprotection and neuropsychiatric disorders.